Skip to main content
INNV logo

INNV

InnovAge Holding Corp.
$12.11 +0.12 (+1.00%) At close · Jul 6
Market Cap
$1.59B
Shares
135,736,393

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$12.11 Open$11.93 Day$11.57–12.44 52W$3.13–12.64 Avg vol 30d416K Short int767K · 0.6% float · 2.1d Short vol53% Last earningsMay 5, 2026 DataMar 2021–Jul 2026 Filing10-Q · May 8
Equibles Rating blended score · not investment advice
Overall
Buy
Technical · trend & momentum Buy
50 / 200-day cross no cross
+ Price vs 200-day avg +75% above
+ Price vs 50-day avg +43% above
RSI (14) 85 · overbought
+ MACD trend positive
+ 52-week position 94% · near high
Sentiment · smart money Bullish
Trend (MA cross) 50d $8 › 200d $7 — 50d above 200d
Institutional flow 2 of 103 funds reported for Jun 30 · net -13.0K sh shares
Insider flow No net insider activity over 90 days
+ Short interest 0.57% of float · ▼ -33.4% MoM · 2.1 days cover
Volume signal Volume near normal
+ Institution breadth 103 holders — near 3-yr high, broad support
Fundamentals Excellent
+ Revenue growth +12% Y/Y
+ Gross margin 18%, expanding
EPS growth −38% Y/Y
+ Free cash flow $26.6M
+ Buyback $7.5M authorized
+ Balance sheet net cash $4.1M

Blended from price, positioning & fundamentals · daily-close · not investment advice.

Up next
Next earnings call
Aug 4, 2026 Est · unconfirmed · in 4 wks
FQ1-27 quarter ends
~Sep 30, 2026 Est
filed May 8, 2026

Technicals

trend & momentum for long-term holders Buy
1 · 1 · 4
50 / 200-day cross
no cross Neutral
Price vs 200-day avg
+75% above Bullish
Price vs 50-day avg
+43% above Bullish
RSI (14)
85 · overbought Bearish
MACD trend
positive Bullish
52-week position
94% · near high Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $8 › 200d $7 — 50d above 200d
Institutional flow Distributing
2 of 103 funds reported for Jun 30 · net -13.0K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.57% of float · ▼ -33.4% MoM · 2.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
103 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $3 Now $12 · 94% 52-wk high $13
vs 200-day avg +75% vs 50-day avg +43%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings
Metric Latest Period YoY
Census 8,050 Three Months Ended March 31, 2026

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
INNV
InnovAge Holding Corp.
this stock
$1.59B +133.3% +11.8% 0.6%
HCA
HCA Healthcare, Inc.
$94.07B -10.5% +7.1% 14.6 2.4%
FSNUY
Fresenius SE & Co. KGaA
$28.14B -12.8% 0.0%
THC
Tenet Healthcare Corp
$17.76B +3.8% -2.3% 10.7 4.7%
DVA
Davita Inc.
$15.13B +107.5% +6.5% 22.0 7.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
102
% held
11.7%
Reported
2 of 103
Top holder
T. Rowe Price Investment…
Held Float
View
Held by Funds
Fund positions
117
View
Short & Settlement
Short Interest Falling
Shares short
767.5K
Days to cover
2.1d
Change
-384.8K sh
View
Short Volume
Short vol %
53%
As of
Jul 7, 2026
Short Total
View
Fails to Deliver
FTD shares
383
Value
$2.8K
As of
Jun 3, 2026
View
Off-Exchange
Off-exchange %
31.8%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$853.7M
Net income (FY)
$-30.3M
EPS diluted
$-0.22
View
Buybacks
Authorized · 2 programs
$7.5M
View
Filings
SEC Filings
Latest
8-K
Filed
May 18, 2026
This year
9
View
Proposed Sales
Value
$169.3K
Shares
33.0K
Filed
Nov 14, 2025
View
Earnings & Events
Earnings Calls
Last call
May 5, 2026
View
Investor Relations
Latest news
InnovAge Appoints Jennifer Browne…
Published
May 12, 2026
View

Performance

5D 20D 120D MTD YTD
INNV +12.2% +68.2% +128.5% +2.2% +133.3%
SPY +3.1% -0.8% +8.2% +0.6% +10.2%
vs SPY +9.2% +69.0% +120.3% +1.6% +123.2%

Capital returns

Buyback programs · 2 active · as of Sep 26, 2024
Authorized (total)
$7.50M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1834376 CUSIP 45784A104 13F (30d) 2 filings 2 filers Visit website Investor relations